Associate Principal Scientist
MED Biotech Unit (Respiratory, Inflammation & Autoimmunity)
I am leading the research on understanding how innate lymphoid cells are implicated in driving asthma immunopathology and responses. In my team, the focus is on understanding the role of these cells in acute allergic inflammation but also their function and plasticity during viral infections in the asthmatic airways. Our ultimate goal is to find ways to control their function to ameliorate the burden of the asthmatic patients. Having completed my PhD in molecular cell biology at Uppsala University in 2007, I joined AstraZeneca as a postdoctoral researcher in 2009, which offered a great opportunity to introduce in situ proximity ligation assay (isPLA) on projects within the analgesia and Alzheimer’s disease areas. I successfully established isPLA technology into the company, to strengthen the target validation and show activation of target molecules in human tissue and translatable animal models.
Respiratory, Inflammation & Autoimmunity